Skip to main content

Grand Challenges

Bill & Melinda Gates Foundation

Main menu

  • About
  • Challenges
  • Awarded Grants
  • News
  • Grant Opportunities
  • Search

You are here

  1. Home
  2. Awarded Grants

Print link

Print

Thermostable Vaccines With Improved Stability at Non-Refrigerated Temperatures

Grand Challenges in Global HealthVaccines Without Refrigeration1 Jul 2005

To maintain stability and viability, most childhood vaccines must be kept cool – both heat and freezing can ruin them. Drs. Sarkari and Coeshott and their colleagues are working to identify Pluronic polymer-­based formulations that stabilize vaccines from ­-10°C to 45°C; Their aim is to develop vaccines that are resistant to freezing and form protective matrices at elevated temperatures. Investigators are evaluating formulations based on Pluronic F127 using vaccines for measles and hepatitis B.

More information about Prepare Vaccines that Do Not Require Refrigeration

Share This Awarded Grant

  • Twitter logo Twitter
  • Facebook logo Facebook
  • LinkedIn logo LinkedIn
  • Google+ logo Google+
  • Mailto logo Mailto

Principal Investigator

Claire Coeshott

Organization

Endo Pharmaceuticals, Inc

Location

Boulder, Colorado
United States

Contact us

Contact us

  • General Inquiries
  • Media Inquiries

Footer - Receive Updates

Receive updates

  • Sign up for email updates

Footer

  • Privacy Policy and Terms of Use
© 2003-2018. Grand Challenges. All Rights Reserved.